| Financial Year |
March 31 2023 |
| Monetary Funds |
21,539,210,625.95 |
| Held-for-trading Financial Assets |
21,140,455.47 |
| Notes Receivable |
305,173,871.02 |
| Accounts Receivable |
15,796,077,162.18 |
| Advances to Suppliers |
3,590,989,730.11 |
| Other Receivables |
3,655,413,639.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,177,872,131.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,620,992,768.29 |
| Other Current Assets |
11,563,779,384.15 |
| Total Current Assets |
128,824,139,276.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,181,566,686.87 |
| Long-term Equity Investment |
4,392,301,277.90 |
| Investment Properties |
359,192,349.59 |
| Fixed Assetes |
3,752,923,725.05 |
| Under-construction Projects |
2,918,754,234.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,157,826,470.02 |
| R&D expenses |
15,805,600.69 |
| Goodwill |
24,652,230.06 |
| Long-Term Deferred and Prepaid Expenses |
820,495,850.73 |
| Deferred Income Tax Assets |
526,326,425.55 |
| Other Non-Current Assets |
18,152,175,823.62 |
| Sub-Total of Non-Current Assets |
79,710,491,834.32 |
| Total Assets |
208,534,631,110.41 |
| Short-Term Loans |
1,861,330,106.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
845,868,527.64 |
| Accounts Payable |
62,740,408,289.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
861,861,289.40 |
| Taxes Payable |
1,915,351,354.35 |
| Interest Payable |
-- |
| Dividend Payable |
112,057,476.26 |
| Other payables |
10,005,771,852.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,020,236,279.63 |
| Other Current Liabilities |
13,695,942,817.73 |
| Sub-Total of Current Liabilities |
102,431,739,721.57 |
| Long-term Loans |
52,121,582,212.75 |
| Bonds Payable |
2,044,542,698.82 |
| Long-Term Accounts Payable |
31,748,480.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
656,428,689.95 |
| Deferred Income Tax Liabilities |
415,981,752.25 |
| Other Non-Current Liabilities |
1,299,655,857.31 |
| Sub-Total of Non-Current Liabilities |
57,096,872,982.45 |
| Total Liabilities |
159,528,612,704.02 |
| Paid-In Capital(Or Share Stock) |
6,225,412,975.00 |
| Capital Surplus |
8,335,929,901.38 |
| Surplus Reserve |
1,696,666,070.37 |
| LESS:Treasury Stock |
211,337,438.12 |
| Undistributed Profits |
27,327,514,095.36 |
| Minority Stockholder's Interest |
4,328,031,541.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
44,677,986,864.60 |
| Owner's Equity（Stockholder's Equity） |
49,006,018,406.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
208,534,631,110.41 |
